Physician profile
William James Graugnard
NPI 1972948552
$7,405.31
in general payments reported to CMS, 2019-2025
35 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $852 · 2020: $901 · 2021: $1,550 · 2022: $913 · 2023: $929 · 2024: $983 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,189.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,794.62 | 2019-2025 | Proclaim, Eterna |
| Nevro Corp. | $1,162.96 | 2021-2024 | Senza |
| Relievant Medsystems, INC. | $795.49 | 2021-2023 | Intracept |
| Globus Medical, INC. | $454.98 | 2025 | Senza, Omnia, Vyrsa V1 |
| Collegium Pharmaceutical, INC. | $340.83 | 2019-2023 | Belbuca |
| Boston Scientific Corporation | $339.64 | 2021-2025 | Intracept, General - Pain Management |
| Merz Pharmaceuticals, LLC | $302.97 | 2021-2025 | Xeomin |
| Medtronic, INC. | $263.59 | 2021-2025 | Inceptiv, Accurian, Intellis Adaptivestim |
| Carlsmed, INC. | $253.16 | 2025 | Aprevo |
| Abbvie INC. | $239.69 | 2021-2025 | |
| Saol Therapeutics INC. | $228.04 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.77 | 2019-2022 | |
| Allergan, INC. | $134.31 | 2019-2021 | |
| Horizon Therapeutics Plc | $124.08 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $114.36 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $87.43 | 2022 | |
| Saluda Medical Americas, INC. | $83.90 | 2025 | Evoke |
| Pfizer INC. | $62.34 | 2019 | |
| Scilex Pharmaceuticals INC. | $55.77 | 2019-2020 | |
| Almatica Pharma LLC | $39.71 | 2021 | |
| Azurity Pharmaceuticals, INC. | $38.18 | 2023-2024 | Horizant, Horizant |
| Valinor Pharma, LLC | $35.95 | 2023-2024 | Movantik |
| Biotronik Nro, INC. | $34.26 | 2025 | |
| Stryker Corporation | $33.82 | 2023 | Ivas, Omnicurve |
| Nalu Medical, INC. | $32.86 | 2021-2024 | Nalu Neurostimulation System |
| Lilly USA, LLC | $25.35 | 2024 | Zepbound |
| Assertio Therapeutics, INC. | $24.23 | 2019 | |
| Lundbeck LLC | $17.69 | 2022 | |
| Redhill Biopharma INC. | $16.49 | 2021 | |
| Stimwave Technologies Incorporated | $15.57 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $15.48 | 2021 | |
| Novo Nordisk INC | $15.09 | 2024 | Wegovy |
| Vertex Pharmaceuticals Incorporated | $14.89 | 2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $12.55 | 2022 | |
| Zyla Life Sciences, INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Graugnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.